Technology Platforms

Oligonucleotide Modification

Sugar, base, backbone, terminal, and conjugation modifications for ASO, siRNA, guide RNA, aptamer, and research or labeling oligo projects.

How this supports a project

Oligonucleotide material selection starts with the complete strand design: sequence, position-by-position modification map, backbone pattern, 3′ support, termini, internal handles, cleavage and deprotection conditions, and analytical plan.

Translate the strand design into material requirements

A modification name does not specify an oligonucleotide. Each residue must be assigned to a position and strand, and the design must also identify backbone linkages, terminal groups, overhangs, solid support or 3′ linker, and any internal or terminal conjugation site.

Protected monomers, support chemistry, oxidation or sulfurization, capping, cleavage, and deprotection must be compatible as one process. A terminal dye, lipid, GalNAc ligand, cholesterol derivative, or click handle can also change the required support, protecting-group strategy, purification, and analytical methods.

Typical material-definition workflow

1

Define every strand

Provide sequence, orientation, strand role, length, overhangs, and intended duplex or single-strand format.

2

Map every modification

Assign sugar, base, backbone, stereochemical where applicable, terminal, and internal modifications to exact positions.

3

Select monomers and support

Match protected phosphoramidites or other monomers and the solid support or 3′ linker to the construct and cleavage plan.

4

Set cycle and deprotection chemistry

Define coupling, capping, oxidation or sulfurization, cleavage, and deprotection conditions and check all modified units for compatibility.

5

Plan conjugation

Specify ligand or reporter identity, attachment position, spacer, reaction pair, installation stage, and protection or purification needs.

6

Define analytical confirmation

Set methods for strand identity, purity, mass, modification or conjugate confirmation, related species, duplex formation where relevant, and material form.

Inputs for platform review

Full construct map

Sequence and exact positions of all modified sugars, bases, backbone linkages, termini, overhangs, and conjugation sites.

Synthesis format

DNA, RNA, mixed chemistry, strand count, synthesis scale, solid-support or 3′-end requirement, and intended material form.

Process constraints

Required or prohibited protecting groups, activation, oxidation or sulfurization, cleavage, deprotection, solvent, and temperature conditions.

Conjugate definition

Exact ligand, lipid, dye, biotin, chelator, or click handle; attachment position, spacer, and reaction sequence.

Analytical specification

Required identity, purity, mass, modification confirmation, residuals, counterion or salt, water content, and storage condition.

Where this platform applies

This platform covers modified monomers, supports, sulfurizing or related synthesis reagents, terminal and internal handles, and conjugation-ready building blocks. It does not provide sequence design, target selection, silencing or binding predictions, validated delivery, biological efficacy, safety, clinical suitability, or regulatory status. Those conclusions require construct-specific experimental evidence.

Core considerations

  • 2'-OMe, 2'-F, LNA, MOE, and related building blocks
  • Backbone and terminal modification support
  • GalNAc, lipid, dye, and click conjugation handles

Related catalog and technical pages

Sources

  1. 1.Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing (Journal of Organic Chemistry, 2021)
  2. 2.Solid-phase supports for oligonucleotide synthesis (Current Protocols in Nucleic Acid Chemistry, 2013)
  3. 3.The chemical evolution of oligonucleotide therapies of clinical utility (Nucleic Acids Research, 2017)
  4. 4.Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications (Molecules, 2019)